HIVE vs OPY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: May 12, 2026

HIVE

59.5
AI Score
VS
HIVE Wins

OPY

57.5
AI Score

Investment Advisor Scores

HIVE

60score
Recommendation
HOLD

OPY

58score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HIVE OPY Winner
Forward P/E 47.1698 10.8108 OPY
PEG Ratio 0 12 Tie
Revenue Growth 218.6% 27.8% HIVE
Earnings Growth -99.9% 588.5% OPY
Tradestie Score 59.5/100 57.5/100 HIVE
Profit Margin -48.6% 9.6% OPY
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.